Aliskiren (Tekturna)

aliskiren · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Aliskiren (Tekturna), covering 2013-01-30 to 2013-01-30. Get the full timeline:

Most recent: Clinical Trial Update: To Study the Effects of Aliskiren on Albuminuria and Various Biomarkers in Patients With Nephropathy [Phase 2]